Metabolomics Breakthrough Advances CAR T Safety Science
MORRISVILLE, NORTH CAROLINA, UNITED STATES — February 17, 2026 Metabolon announced that its global metabolomics platform has enabled the...
Biomarkers
Advertisement
FDA CRL Delays Bitopertin Approval for Rare EPP Disease
WATERTOWN, Mass., Feb. 13, 2026 — Disc Medicine announced that the U.S. Food and Drug Administration has issued a...
Alto Completes Phase 2 Enrollment for CIAS Drug
MOUNTAIN VIEW, Calif., Feb. 13, 2026 — Alto Neuroscience announced completion of patient enrollment in its Phase 2 proof-of-concept...
Tau Immunotherapy AADvac1 Enters Landmark AD Trial
SAN FRANCISCO, Calif., Feb. 4, 2026 — Axon Neuroscience announced that its active tau immunotherapy AADvac1 has been selected...
RNA Methylation Biomarkers Expand Liquid Biopsy Cancer Detection
HEIDELBERG, Germany, December 16, 2025 — Hummingbird Diagnostics GmbH has published a peer-reviewed study revealing a novel approach to...
Advertisements
AC Immune’s Phase 2 Data Shows Promise in Slowing Parkinson’s Progression
LAUSANNE, Switzerland — December 11, 2025 — AC Immune SA has released positive interim Phase 2 data for its...
BriaCell Reveals New Phase 2 and Phase 3 Data Ahead of SABCS 2025
Philadelphia, PA and Vancouver, BC — December 2, 2025 — BriaCell Therapeutics Corp. announced plans to present three major...
Creative Medical Technology Pioneers Regenerative Immunotherapy with AI-Enhanced Cell Platforms
Phoenix, AZ – October 27, 2025: Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), a clinical-stage biotechnology company, has issued...
Sanofi Q3 2025 Results: Strong Growth and Key Approvals
PARIS – October 24, 2025 Sanofi reported a 7.0% sales increase at constant exchange rates (CER) for Q3 2025,...
Labcorp Expands Alzheimer’s Detection with FDA-Cleared Test
BURLINGTON, N.C. – October 23, 2025 Labcorp (NYSE: LH), a global leader in laboratory diagnostics, announced it will soon...
Advertisement
